Literature DB >> 9668240

AChR channel blockade by quinidine sulfate reduces channel open duration in the slow-channel congenital myasthenic syndrome.

T Fukudome1, K Ohno, J M Brengman, A G Engel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9668240     DOI： 10.1111/j.1749-6632.1998.tb10928.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

Review 1.  Nicotinic acetylcholine receptors at the single-channel level.

Authors:  Cecilia Bouzat; Steven M Sine
Journal:  Br J Pharmacol       Date:  2017-04-08       Impact factor: 8.739

2.  Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome.

Authors:  Haipeng Zhu; Gary E Grajales-Reyes; Vivianette Alicea-Vázquez; Jose G Grajales-Reyes; KaReisha Robinson; Peter Pytel; Carlos A Báez-Pagán; Jose A Lasalde-Dominicci; Christopher M Gomez
Journal:  Exp Neurol       Date:  2014-10-23       Impact factor: 5.330

3.  Acetylcholine receptor gating in a zebrafish model for slow-channel syndrome.

Authors:  Michael Walogorsky; Rebecca Mongeon; Hua Wen; Gail Mandel; Paul Brehm
Journal:  J Neurosci       Date:  2012-06-06       Impact factor: 6.167

4.  Zebrafish model for congenital myasthenic syndrome reveals mechanisms causal to developmental recovery.

Authors:  Michael Walogorsky; Rebecca Mongeon; Hua Wen; Nathan R Nelson; Jason M Urban; Fumihito Ono; Gail Mandel; Paul Brehm
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

Review 5.  Decoding pathogenesis of slow-channel congenital myasthenic syndromes using recombinant expression and mice models.

Authors:  José David Otero-Cruz; Carlos Alberto Báez-Pagán; Luisamari Dorna-Pérez; Gary Emanuel Grajales-Reyes; Rosaura Teresa Ramírez-Ordoñez; Carlos A Luciano; Christopher Manuel Gómez; José Antonio Lasalde-Dominicci
Journal:  P R Health Sci J       Date:  2010-03       Impact factor: 0.705

6.  Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia.

Authors:  Li Di; Hai Chen; Yan Lu; Duygu Selcen; Andrew G Engel; Yuwei Da; Xin-Ming Shen
Journal:  Neurology       Date:  2020-09-09       Impact factor: 9.910

7.  Effects of Quinine, Quinidine and Chloroquine on Human Muscle Nicotinic Acetylcholine Receptors.

Authors:  Günter Gisselmann; Desiree Alisch; Brigitte Welbers-Joop; Hanns Hatt
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.